Back to newsroom

Emm Secures UK Regulatory Clearance for World’s First Smart Menstrual Cup

UKCA mark accelerates global effort to bridge the gender health data gap

2026-06-24

LONDON, UK. June 24, 2026 - Emm, a pioneer in biowearable technology, today announced that the Emm Cup has officially secured UKCA marking and MHRA registration. This milestone establishes the device as the world's first regulatory cleared smart menstrual cup, moving menstrual tracking from manual calendar estimates to precise, automated biometric measurement.

While consumer health technology has successfully automated the continuous tracking of sleep, heart rate, stress, recovery, and glucose, reproductive health has historically lagged behind. Consumers have been forced to rely on personal recall, subjective estimates, and calendar predictions. Today that changes.

“UKCA marking validates our technology requirements and opens the door for millions of people to truly know their health today and screen for their health tomorrow,” said Jenny Button, Founder and CEO of Emm. “For too long, a critical data gap in women's health has led to delayed diagnoses and the routine dismissal of pain. We believe our technology can act as a catalyst to unlock some of the world's least understood reproductive health challenges, turning subjective symptoms into objective, actionable data.”

The Emm Cup is the world's first passive biowearable for women's reproductive health, measuring precise flow volume, daily flow rates, and overall cycle patterns, and occupying a biological interface no other device holds. 

Manufactured with medical-grade hypoallergenic silicone, the smart cup captures data passively, syncing to a private, encrypted smartphone app only when docked in its portable charging case. The resulting baseline data gives users actionable insights into their reproductive health, allowing them to spot cycle changes over time and confidently share objective metrics with healthcare professionals.

Emm is now moving forward with regulatory expansion, pursuing U.S. FDA clearance and ISO 13485 certification to support a broader international rollout.

To learn more about the technology or to join the Emm community, please visit emm.co

Notes to editors 

For more information, please contact press@emm.co. 

 

About Emm

Emm is a health intelligence company and pioneer in biowearable innovation, dedicated to closing the gender health data gap. The company developed the Emm Cup, the world’s first regulatory-approved smart menstrual cup, marking the beginning of a lifetime health partnership from puberty through menopause. Emm is building a critical menstrual and reproductive health data layer of objective, continuous baseline data that does not currently exist at scale. By establishing the definitive phenotypic dataset for menstruation, Emm aims to fundamentally change the future of personalized reproductive care, screening, and diagnostic support for women.  To learn more, visit www.emm.co